Forthcoming Events
This is the FIRST live streamed only, One day professional conference discussing Cancer Pathology. We have gathered together invited speakers from around the world, who…
& Who Should Attend:
Anyone with an interest in Recent Trends in Novel Drug Delivery System like Pharma companies, research scientists, academicians will find this…
This live streamed event will focus on recent trends and advancements in the field of Analytical & bioanalytical Chemistry,Practical challenges encountered and the solutions adopted…
Who Should Attend: Who Should Attend:
Anyone with an interest in pediatrics & pediatric education will find this event useful, including Physician, General Pediatrician,
Registered nurses,Nurse…
& Who Should Attend:
Anyone with an interest in working within the field of dental science, dentists, Maxillofacial surgeons, oral care specialists, research scientists, pharma…
& Who Should Attend:
Anyone with an interest in New Trends in Nano Science & Nanotechnology, like Nano Scientists, Academicians working in the field of…
& Who Should Attend:
Anyone with an interest in Applied Microbiology like Microbiologists, Biomedical scientists, Clinical researchers, Food technologists, Pharmacologists, Physicians, Ecologist and Forensic scientists…
& Who Should Attend:
Anyone with an interest in Frontiers in Neurology & Neuroscience, Neuroscientists, Neroanatomist, Neurobiologists, Neurochemist,Neurological Surgeon,Psychiatrist, Psychophysicist will find this event useful….
This event will focus on managing the health concerns of the mother and fetus prior to, during, and shortly after pregnancy.
Discussing the latest advances in clinical and laboratory-based research for treatment of cancer.
Industry Updates
Sense About Science
Euroscicon Meeting Feedback
More About Our Events
Comments Off on Deadlines approaching for The Science of Pain and its Management
This is the FIRST live streamed only, three day professional conference discussing the Science of Pain.
We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Comments Off on Bacteriophage 2017: Early registration discount deadline approaching
This is the FIRST live streamed only, three day professional conference discussing Bacteriophages.
We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Oral presentation submission deadline – 10th October 2016
Early registration deadline – 20th November 2016
Comments Off on Fees will increase on the 20th Sept for the 2016 Sleep Summit
This international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of sleep related issues and disorders
Early registration discount –
20th September 2016
Book now to avoid increased fees
Comments Off on Advancing pathology for cancer diagnosis, staging and prognosis. 16th October 2017
This is the FIRST live streamed only, One day professional conference discussing Cancer Pathology. We have gathered together invited speakers from around the world, who…
Comments Off on Recent Trends in Novel Drug Delivery System 8th- 9th November
& Who Should Attend:
Anyone with an interest in Recent Trends in Novel Drug Delivery System like Pharma companies, research scientists, academicians will find this…
Comments Off on Advances in Analytical & Bioanalytical Chemistry 27th-28th November
This live streamed event will focus on recent trends and advancements in the field of Analytical & bioanalytical Chemistry,Practical challenges encountered and the solutions adopted…
Comments Off on The Biomedical Scientist publishes meeting report from Euroscicon’s Pathology 2015
& Euroscicon are pleased to announce that a meeting report from Pathology 2015 has been published in The Biomedical Scientist: Sergi CM. Degenerative and oncologic…
Comments Off on Meeting report from Euroscicon’s 2015 Innate Immunity Summit published in Future Virology
Euroscicon are pleased to announce that a meeting report from The 2015 Innate Immunity Summit has been published in Future Virology: The EuroSciCon’s 2015 Innate…
Comments Off on Dr John Gill’s Talk from Biobanking 2016 published in Future Virology
Dr John Gill’s talk from Euroscicon’s 2016 Biobanking Conference has been
published in Future Virology
Comments Off on Congratulations to prizewinner from Euroscicon’s Rare Metabolic Disorders 2016 event
Congratulations to prizewinner from Euroscicon’s Rare Metabolic Disorders 2016 event
Comments Off on Congratulations to prize winners from The 2016 TB Summit
Congratulations to prize winners from The 2016 TB Summit
Comments Off on The 2016 Alzheimer’s Disease Congress – Congratulations to prize winners
Congratulations to our poster prize winners
Dr Vicky Jones (University of Central Lancashire, UK)
ABERRANT CELLULAR MORPHOLOGY IN INDUCED HUMAN ASTROCYTE MODELS OF
ALZHEIMER’S DISEASE.
I am recruiting for a part time analytical chemist to join a biotechnology company based in Glasgow that is very highly regarded in the industry…
Department of Pure Mathematics and Mathematical Statistics Herchel Smith Postdoctoral Research Fellowship in Pure Mathematics Salary: ?29,301 to ?38,183 pa Fixed-term:
The funds for…
7th Bio/Pharma Logistics Exhibition Conference - Cool Supply Systems & Solutions, CSS + companies, on 15th and 16th of March 2017. and Solution providers committed to Good Distribution Practice EU guidelines focused on transport, logistics, distribution, Thermal Packaging, Data Monitoring among others, can meet with key decision makers from the top 100 Bio/Pharmaceutical companies [&]
Meeting Reports
Euroscicon Supports The Following CharitiesEuroSciCon Conference on
Clinical Cardiology
Theme: Leading edge in the field of Cardiology
Event Location
London, UK
16 years of lifescience communication
Quick Links
Academic Key Topics
Business Key Topics
Clinical Cardiology 2018
Event begins in
About Conference
The&EuroSciCon&will be holding its CPD accredited&for Clinical Cardiology conference May 24-26, 2018 London, UK.&The theme of this year&s meeting is &Leading edge in the field of Cardiology& which will provide an international platform for discussion of present and future challenges in cardiac diseases, prevention and treatment of myocardial abnormalities, new inventions in technology. World-leading health practitioners, clinicians, educators and researchers will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.
What&s New?
Clinical Cardiology 2018 includes international attendee workshops, lectures and symposia, including a designated registration area, a refreshment break and gala lunch.&&Cardiologists, Cardiovascular researchers can join the EuroSciCon as an international member to receive discounts on registration. So come and join leading experts and allied professionals from May 24-26 &2018 in London, UK to keep up with the rapidly accelerating pace of change that is already having an impact on the field clinical cardiology and will continue to in the future.
Why London?
London is the capital and most populous city of England and the United Kingdom. Standing on the River Thames in the south east of the island of Great Britain, London has been a major settlement for two millennia. Since at least the 19th century, &London& has also referred to the metropolis around this core, historically split between Middlesex, Essex, Surrey, Kent, and Hertfordshire, which today largely makes up Greater London, governed by the Mayor of London and the London Assembly. London is the world's leading investment destination, hosting more international retailers and ultra-high-net-worth individuals than any other city. London's universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. London has a diverse range of people and cultures, and more than 300 languages are spoken in the region. It&s estimated mid-2015 municipal population was 8,673,713, the largest of any city in the European Union, and accounting for 12.5 per cent of the UK population. London's urban area is the second most populous in the EU, after Paris, with 9,787,426 inhabitants at the 2011 census. The iconic &Big Ben& clock tower and Westminster Abbey, site of British monarch coronations. Across the Thames River, the London Eye observation wheel provides panoramic views of the South Bank cultural complex, and the entire city.
Sessions & Tracks
Cardiovascular Disease:
Cardiovascular diseases are universal cause leading to increased mortality.&This is worldwide fact except in Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015 up from 12.3 million (25.8%) in 1990.&Deaths, at a given age, due to cardiovascular diseases are more common and have been increasing in much of the&developing countries, while rates have declined in most of the&developed countries&since 1970s.&Coronary artery disease and stroke constitute for 80% of CVD deaths in males and 75% of CVD deaths in females.&Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 suffer from CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD.&The average count of deaths from coronary artery disease in the developed world is around 80 years of age while it is around 68 years in the developing world.&Disease onset is generally seven to ten years earlier in men as compared to women.
Atherosclerosis
Coronary artery disease
Cardiomyopathy
Transient ischemic attacks( angina pectoris and myocardial infarction)
Cardiac defects in pregnancy
Cardiac Medications:
Cardiovascular drugs are used to treat the abnormal conditions of heart or circulatory system or vascular system. They are a group of complicated drugs which are used to treat multiple heart conditions. Cardiac medications are used to increase the blood supply and to decrease the work load on the heart. This sub-topic includes alpha, beta blockers, angiotensin II receptor blockers, dual antiplatelet therapy, ACE inhibitors, digoxin preparations, diuretics and vasodilators. There are 120 Companies in USA that are making Cardiac Therapeutic Agents in Cardiology. Around 6 new drugs were introduced in 2015 and 2 drugs were introduced in 2016. There are many types of cardiovascular drugs in the market that include Corlanor (ivabradine), Kanuma (sebelipase alfa), Byvalson (nebivolol and valsartan), and Yosprala (aspirin and omeprazole).
Alpha and beta blockers
Angiotensin-II receptor blockers
Dual antiplatelet therapy
Angiotensin converting enzyme inhibitors
Digoxin preparations, diuretic and vasodilators
Pediatric Cardiology:
Pediatric Cardiology plays a major role in the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and for the ongoing management of the sequel of heart disease in infants, children and adolescents. The inclined graph of neonates with congenital heart defects referred to the neonatal intensive care unit reflects the increasing awareness that the defects may be present.&Chest radiography and ECG rarely used in the neonatal diagnosis.&Congestive heart failure&in the fetus, or hydrops, can be detected by performing fetal echocardiography. Nursing and care for pediatric cardiac patients also plays an important role for the cure of pediatric cardiac patients.
Patent ductus arteriosus
Atrial septal defect
Hypoplastic left heart syndrome
Pediatric cardiac tumors
Specific congenital heart defects
Heart as Functional Syncytium:
Heart is a major muscular organ in humans and animals. It plays a crucial role in supply of blood, a fluid connective tissue to the various parts of the body. It&provides the body with&oxygen&and&nutrients and also directs in the removal of&metabolic wastes. Heart is divided into four chambers: upper left and right&atria and lower left and right&ventricles. Heart consists of heart valves which prevent the backflow. The wall of heart consists of three layers namely epicardium, endocardium and myocardium. The heart pumps the blood with the help of a rhythm proposed by a group of pacemaking cells in sinoatrial node. This causes contraction of heart and generates a current which travels along the conduction system of heart. During this process the blood low in oxygen enters the heart where the oxygen is used and gets metabolized to carbon dioxide and is transferred to lungs.
Pathways of veins, arteries and capillaries
Thermoregulation
Protection from infections
Hormonal delivery
Cardiac Surgeries:
The surgeries done on the vessels of heart by the cardiac surgeons are known as cardiac surgery. Cardiac surgeries are implemented to treat ischemic heart diseases, congenital heart diseases, rheumatic heart disease including endocarditis. It also includes heart transplantation. Cardiopulmonary bypassechniques has reduced the mortality rates of these surgeries to relatively low ranks. Coronary artery bypass grafting (CABG) is the most common type of heart surgery. CABG improves blood flow to the heart. Surgeons use CABG to treat people who have severe coronary heart disease (CHD).
Open heart surgery
Coronary artery bypass grafting
Transmyocardial laser revascularization
Cardiothoracic Surgery
Pediatric cardiovascular surgery
Congenital Heart Block:
Congenital heart block is a rare disorder which has an occurrence of about 1 in 22,000 live births. The underlying cause for congenital heart block is any disturbances in the transfer of electrical nerve impulses that regulate the normal rhythmic, pumping action of cardiac muscle. If the transmission of the electrical signal is obstructed, the blocked transmission is known as heart block or AV block. If the blockade occurs in fetus or new born then the condition is known as congenital heart block. Thus condition neither alters the flow of blood nor cause any blockage or damage to the major or minor coronary arteries.
Neonatal lupus syndrome
Congenital heart block in adults
Fetal heart block in pregnancy
Congenital heart block with sjoren syndrome
Cardiac Remodeling:
Cardiac remodeling also known as ventricular remodeling is defined as altered genomic expression leading to molecular, cellular and interstitial changes which cause changes in shape, size, structure and function of the heart. Cardiac myocyte is the major cell involved in cardiac remodeling. The underlying cause for cardiac remodeling may be physiological or pathological remodeling, cardiac load, hemodynamic load, neurohumoral activation. Chronic hypertension, valvular heart disease, congenital heart disease may also lead to cardiac remodeling. Cardiac remodeling may further lead to myocardial necrosis and disproportionate thinning of heart.
Hypertensive ventricular remodeling
Atrial remodeling
Reverse cardiac modeling
Medication for cardiac remodeling
Advanced devices used to treat Cardiac Diseases:
Cardiac diseases can be treated with the help of various implantable devices. Individuals suffering with serious arrhythmias and heart blocks are the subjects for implantable defibrillators. People with heart failure develop abnormal conduction of the heart&s electrical system that changes the regular rhythms of heart. Cardiac resynchronization therapy, also known as biventricular pacing, serves as one of the method for cardiac treatment. A left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device which is implanted in the body surgically. Coronary artery bypass surgery diverts the blood supply around a blocked section of the artery. During this procedure, surgeons isolate healthy blood vessels from another part of the body, such as a leg or the chest wall. They then surgically attach the vessels to the diseased artery in such a way that the blood can flow around the blocked section.
Left ventricular assist device
Implantable cardioverter defibrillators
Cardiac resynchronization therapy
Intra-aortic balloon pump (IABP)
Cardiovascular Genetics:
The recent and rapid development of molecular genetics in cardiovascular diseases has created a new understanding of their pathogenesis and natural history, and also new possibilities for the diagnosis of these genetic disorders through genetic testing. This has induced new expectations, and new demands, from both families and physicians regarding genetic counselling, DNA testing and application of this knowledge in clinical practice. A new task for cardiologists is therefore to integrate these data in order to give the most relevant information to the patients and the relatives, to discuss genetic testing, and to use the data to optimise the management of the family. At the same time the various impacts of genetic management such as psychological, social, ethical and legal issues should be recognised, anticipated and taken into account. This is possible through a close collaboration between cardiologists and members of other medical or non?EUR?medical disciplines such as geneticists, genetic counsellors, psychologists, and molecular biologists.
Genetics of Congenital Heart Disease
Genetic epidemiology and translational cardiovascular genomics\
Cardiovascular Endocrinology
Genetic Cardiomyopathies
Genetic Epidemology
Stem Cell Therapy in Cardiology:
Heart failure is a condition in which the heart is not able to pump enough blood throughout the body for its normal function. The cause of this can be either functional or structural disorder of the heart. Common causes of heart failure include cardiomyopathy, hypertension, heart valve problems and coronary artery disease. There is no heart failure cure. With respect to the heart, stem cells have the ability to not only home into the damaged areas but also to initiate a cascade of biological events which both culminate in healing of the heart muscle. For example, animal studies have demonstrated that stem cell therapy will cause new muscle cells to be formed through stimulation of dormant stem cells that are already inside the heart muscle. In these studies, the administered stem cell also transformed into new heart muscle cells.
Heart stem surgery
Stem cell heart regeneration
Stem cell therapy for congestive heart failure
Current status of cell therapy in cardiomyopathy
Invasive Techniques for Diagnosis and Treatment:
Invasive diagnostic and therapeutic techniques are indispensable for the diagnosis and interventional treatment of coronary artery disease, valvular involvement and, in particular, if the specific components of the inflammatory or degenerative processes in rheumatic disease are to be identified in the different components of the heart. Although impairment of cardiac function and ischaemia can be suspected also by non-invasive techniques, coronary involvement needs the final proof by angiography. Endomyocardial or epicardial biopsy identifies the key players of autoreactivity: the infiltrating cells and the bound and circulating antibodies. Before corticoid treatment is started, a viral or microbial aetiology has to be excluded at the site of cardiac inflammation. This again can only be done by the analysis of cardiac tissue samples.
Left and right catheterization and angiography
Endomyocardial biopsy
Pericardiocentesis and pericardiopsy
Epicardial and pericardial biopsy
Non Invasive Imaging:
Non-invasive cardiac imaging is mostly used to detect the presence of any heart disease. Recently, with advancements in imaging technology, non-invasive imaging has also been used for the detection of presence, severity and prognosis of the cardiac disease. Cardiac magnetic resonance imaging is a non-invasive tool to evaluate congenital heart disease in children and adults. Coronary CT angiography and MRI of coronary arteries provide an anatomical assessment of coronary stenosis, whereas the hemodynamic significance of a coronary artery stenosis can be assessed by stress myocardial perfusion imaging.
Functional imaging
Anatomical imaging
Stress echocardiography
Positron emission tomography
Nano-technology in Cardio science:
The field of nanotechnology is growing explosively and impinging on all walks of life.&Nanotechnology proved to be promising to improve the diagnosis and treatment of heart, lung and blood diseases. Nanotechnology-based local drug delivery has the potential to achieve restenosis prevention while not impeding endothelial healing. Molecularly targeted drugs can be aimed to specifically bind to epitopes in the injured media and adventitia. Nanotechnology can be used in the imaging of atherosclerosis, detection of vulnerable plaque and treatment of vascular stenosis.
Nano-carriers against atherosclerotic plaques
Polysaccharide Nano systems for Future Progress in Cardiovascular Diseases
Transmyocardial Revascularization (TMR) by Medical Nanomaterial
Nano Artificial Heart Valve Surgery
Nanotechnology for Cardiac Tissue Regeneration
Current research in Cardiology:
Cardiac research is been included as a sub topic in cardiology conferences. This sub topic serves as a platform to exchange new advanced and innovative ideas related to the field of cardiology and search for the optimized techniques to improve cardiac health. &There are 50 associations and societies and the main association for&Interventional cardiology&in USA. 120 universities are working on Current Research in Cardiology.&Some of the& current research topics in&cardiology&&Electrophysiology&and&Arrhythmia Research&Myocardial and Heart Failure Research.
Neuro cardiology
Cardiac complications with endocrinal disorders
Cardiovascular diseases with obesity
Cardiovascular diseases with breast cancer
A huge thanks to all our amazing partners. We couldn’t have a conference without you!
Recent Posts
Talk to Us
Speak directly to one of our conference representatives by calling.
USA/Canada
E-mail us your questions about the conference. We will respond to your questions.
Contact Us
Have questions? We'll be in touch within 24 hours.
Euroscicon ltd.,
Highstone House, 165 High Street,
Barnet, Hertfordshire EN5 5SU, UK
Let&s connect!
EuroSciCon Events are produced by
EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International are accredited with Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.
Request a call back}